DrugMar 8, 2023
Nephron Sterile Compounding Center Norepinephrine Bitartrate in 0.9% Sodium Chloride recall — FDA D-0358-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
Recall history in this database
Classification mix: Class II: 11.
DrugMar 8, 2023
Nephron Sterile Compounding Center Phenylephrine HCl Injection, USP, 1 mg/10 mL recall — FDA D-0359-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugMar 8, 2023
Nephron Sterile Compounding Center Phenylephrine HCl in 0.9% Sodium Chloride Injection, USP recall — FDA D-0362-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugMar 8, 2023
Nephron Sterile Compounding Center Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 recall — FDA D-0355-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugMar 8, 2023
Nephron Sterile Compounding Center Phenylephrine HCl Injection, USP, 0.4 mg/10 mL recall — FDA D-0360-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugMar 8, 2023
Nephron Sterile Compounding Center Norepinephrine Bitartrate in 0.9% Sodium Chloride recall — FDA D-0357-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugMar 8, 2023
Nephron Sterile Compounding Center Norepinephrine Bitartrate in 0.9% Sodium Chloride recall — FDA D-0356-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugMar 8, 2023
Nephron Sterile Compounding Center Phenylephrine HCl Injection, USP, 0.8 mg/10 mL recall — FDA D-0361-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugJan 18, 2023
Nephron Sterile Compounding Center Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x recall — FDA D-0099-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugNov 23, 2022
Nephron Sterile Compounding Center PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL recall — FDA D-0065-2023
CGMP Deviations: Potential for cross contamination due to product carry over.
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugNov 23, 2022
Nephron Sterile Compounding Center PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial recall — FDA D-0064-2023
CGMP Deviations: Potential for cross contamination due to product carry over.
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
Understanding this recall history
This page summarizes recall records in which the official source identifies Nephron Sterile Compounding Center LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.